Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acid, Bile
2. Acids, Bile
3. Bile Acids
4. Bile Acids And Salts
5. Bile Salt
6. Bile Salts
7. Salt, Bile
8. Salts, Bile
1. Bile Salt
2. Bile Salts
3. Chebi:22868
4. C01558
| Molecular Weight | 408.6 g/mol |
|---|---|
| Molecular Formula | C24H40O5 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 408.28757437 g/mol |
| Monoisotopic Mass | 408.28757437 g/mol |
| Topological Polar Surface Area | 98 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 637 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 7 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Bile Salts manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bile Salts, including repackagers and relabelers. The FDA regulates Bile Salts manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bile Salts API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bile Salts supplier is an individual or a company that provides Bile Salts active pharmaceutical ingredient (API) or Bile Salts finished formulations upon request. The Bile Salts suppliers may include Bile Salts API manufacturers, exporters, distributors and traders.
click here to find a list of Bile Salts suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bile Salts CEP of the European Pharmacopoeia monograph is often referred to as a Bile Salts Certificate of Suitability (COS). The purpose of a Bile Salts CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bile Salts EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bile Salts to their clients by showing that a Bile Salts CEP has been issued for it. The manufacturer submits a Bile Salts CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bile Salts CEP holder for the record. Additionally, the data presented in the Bile Salts CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bile Salts DMF.
A Bile Salts CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bile Salts CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bile Salts suppliers with CEP (COS) on PharmaCompass.
Bile Salts Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bile Salts GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bile Salts GMP manufacturer or Bile Salts GMP API supplier for your needs.
A Bile Salts CoA (Certificate of Analysis) is a formal document that attests to Bile Salts's compliance with Bile Salts specifications and serves as a tool for batch-level quality control.
Bile Salts CoA mostly includes findings from lab analyses of a specific batch. For each Bile Salts CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bile Salts may be tested according to a variety of international standards, such as European Pharmacopoeia (Bile Salts EP), Bile Salts JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bile Salts USP).
LOOKING FOR A SUPPLIER?
